CSPC PHARMACEUT.GR. ADR4 (CVGU) — Net Asset Quality Index
CSPC PHARMACEUT.GR. ADR4 (CVGU) has a Net Asset Quality Index of 74.0% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €46.70 Billion minus total liabilities of €12.15 Billion yields net assets of €34.55 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See CVGU cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
CSPC PHARMACEUT.GR. ADR4 Net Asset Quality Index Over Time (2021–2025)
This chart shows how CSPC PHARMACEUT.GR. ADR4's Net Asset Quality Index has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the index stands at 74.0%, representing net assets of €34.55 Billion against total assets of €46.70 Billion EUR. Explore CVGU cash flow conversion to assess how effectively this company generates cash.
Annual Net Asset Quality Index for CSPC PHARMACEUT.GR. ADR4 (2021–2025)
The table below presents the year-by-year Net Asset Quality Index for CSPC PHARMACEUT.GR. ADR4 from 2021 to 2025, covering 5 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see CSPC PHARMACEUT.GR. ADR4 market capitalisation.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 74.0% | €34.55 Billion | €46.70 Billion | €12.15 Billion | ▼ -2.3 pp |
| 2024 | 76.3% | €33.87 Billion | €44.39 Billion | €10.52 Billion | ▲ +0.6 pp |
| 2023 | 75.7% | €35.02 Billion | €46.28 Billion | €11.26 Billion | ▼ -0.1 pp |
| 2022 | 75.8% | €31.64 Billion | €41.77 Billion | €10.13 Billion | ▼ -1.5 pp |
| 2021 | 77.2% | €26.83 Billion | €34.74 Billion | €7.91 Billion | — |